Easywell Biomedicals Valuation
| 1799 Stock | TWD 68.60 3.30 4.59% |
At this time, the firm appears to be overvalued. Easywell Biomedicals shows a prevailing Real Value of NT$65.86 per share. The current price of the firm is NT$68.6. Our model computes the value of Easywell Biomedicals from reviewing the firm fundamentals such as Total Debt of 344.06 M, cash and equivalents of 399.51 M, and Debt To Equity of 0.41 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Easywell Biomedicals' price fluctuation is very steady at this time. Calculation of the real value of Easywell Biomedicals is based on 3 months time horizon. Increasing Easywell Biomedicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Easywell stock is determined by what a typical buyer is willing to pay for full or partial control of Easywell Biomedicals. Since Easywell Biomedicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Easywell Stock. However, Easywell Biomedicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 68.6 | Real 65.86 | Hype 68.6 |
The intrinsic value of Easywell Biomedicals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Easywell Biomedicals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Easywell Biomedicals helps investors to forecast how Easywell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Easywell Biomedicals more accurately as focusing exclusively on Easywell Biomedicals' fundamentals will not take into account other important factors: Easywell Biomedicals Total Value Analysis
Easywell Biomedicals is presently anticipated to have takeover price of 0 with market capitalization of 1.2 B, debt of 344.06 M, and cash on hands of 399.51 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Easywell Biomedicals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 1.2 B | 344.06 M | 399.51 M |
Easywell Biomedicals Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Easywell indicates not a very effective usage of assets in November.Easywell Biomedicals Profitability Analysis
Net Loss for the year was (183.52 M) with profit before overhead, payroll, taxes, and interest of 0.About Easywell Biomedicals Valuation
Our relative valuation model uses a comparative analysis of Easywell Biomedicals. We calculate exposure to Easywell Biomedicals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Easywell Biomedicals's related companies.Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan. EASYWELL BIOMEDICAL operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct Easywell Biomedicals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Easywell Biomedicals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Easywell Biomedicals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Easywell Biomedicals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Easywell Biomedicals' revenue streams: Identify Easywell Biomedicals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Easywell Biomedicals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Easywell Biomedicals' growth potential: Evaluate Easywell Biomedicals' management, business model, and growth potential.
- Determine Easywell Biomedicals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Easywell Biomedicals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Easywell Stock Analysis
When running Easywell Biomedicals' price analysis, check to measure Easywell Biomedicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easywell Biomedicals is operating at the current time. Most of Easywell Biomedicals' value examination focuses on studying past and present price action to predict the probability of Easywell Biomedicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easywell Biomedicals' price. Additionally, you may evaluate how the addition of Easywell Biomedicals to your portfolios can decrease your overall portfolio volatility.